Ryan D. Lake
2020 - Baudax Bio
In 2020, Ryan D. Lake earned a total compensation of $322.7K as Chief Financial Officer at Baudax Bio, a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $48,000 |
|---|---|
| Salary | $198,985 |
| Stock Awards | $51,060 |
| Other | $24,673 |
| Total | $322,718 |
Lake received $199K in salary, accounting for 62% of the total pay in 2020.
Lake also received $48K in non-equity incentive plan, $51.1K in stock awards and $24.7K in other compensation.
Rankings
In 2020, Ryan D. Lake's compensation ranked 12,000th out of 13,090 executives tracked by ExecPay. In other words, Lake earned more than 8.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,000 out of 13,090 | 8th |
Division Services | 2,151 out of 2,341 | 8th |
Major group Health Services | 235 out of 252 | 7th |
Industry group Miscellaneous Health And Allied Services, Not | 36 out of 43 | 16th |
Source: SEC filing on March 11, 2021.
Lake's colleagues
We found one more compensation record of an executive who worked with Ryan D. Lake at Baudax Bio in 2020.
2020
Gerri Henwood
Baudax Bio
Chief Executive Officer
News
Recro Pharma CEO J Enloe's 2022 pay jumps 107% to $2.3M
April 6, 2023
Recro Pharma CFO Ryan Lake's 2021 pay jumps 622% to $2.3M
April 1, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020